An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools

被引:41
|
作者
Perry, Rachel [1 ]
Leach, Verity [1 ]
Davies, Philippa [1 ]
Penfold, Chris [1 ]
Ness, Andy [1 ]
Churchill, Rachel [2 ]
机构
[1] Univ Bristol, Bristol, Avon, England
[2] Univ York, York, N Yorkshire, England
关键词
Fibromyalgia; CAM; Systematic reviews; Overview; ROBIS; AMSTAR; RANDOMIZED CLINICAL-TRIAL; CHIROPRACTIC MANAGEMENT; SHAM ACUPUNCTURE; GENERAL-PRACTICE; MEDICINE; PAIN; EFFICACY; METAANALYSIS; GUIDELINES; QUESTIONNAIRE;
D O I
10.1186/s13643-017-0487-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Fibromyalgia (FM) is a chronic, debilitating pain disorder. Dissatisfaction with conventional medicine can lead people with FM to turn to complementary and alternative medicine (CAM). Two previous overviews of systematic reviews of CAM for FM have been published, but they did not assessed for risk of bias in the review process. Methods: Five databases Medline, Embase, AMED (via OVID), Web of Science and Central were searched from their inception to December 2015. Reference lists were hand-searched. We had two aims: the first was to provide an up-to-date and rigorously conducted synthesis of systematic reviews of CAM literature on FM; the second was to evaluate the quality of the available systematic review evidence using two different tools: AMSTAR (Shea et al. BMC Med Res Methodol 15; 7:10, 2007) and a more recently developed tool ROBIS (Whiting et al. J Clin Epidemiol 69:225-34, 2016) specifically designed to assess risk of bias in systematic reviews. Any review that assessed one of eight CAM therapies for participants diagnosed with FM was considered. The individual studies had to be randomised controlled trials where the intervention was compared to placebo, treatment as usual or waitlist controls to be included. The primary outcome measure was pain, and the secondary outcome measure was adverse events. Results: We identified 15 reviews that met inclusion criteria. There was low-quality evidence that acupuncture improves pain compared to no treatment or standard treatment, but good evidence that it is no better than sham acupuncture. The evidence for homoeopathy, spinal manipulation and herbal medicine was limited. Conclusions: Overall, five reviews scored 6 or above using the AMSTAR scale and the inter-rater agreement was good (83.6%), whereas seven reviews achieved a low risk of bias rating using ROBIS and the inter-rater agreement was fair (60.0%). No firm conclusions were drawn for efficacy of either spinal manipulation or homoeopathy for FM. There is limited evidence for topical Capsicum, but further research is required. There is some evidence to support the effectiveness of acupuncture for FM, but further high-quality trials are needed to investigate its benefits, harms and mechanisms of action, compared with no or standard treatment. Systematic review registration: PROSPERO CRD42016035846.
引用
收藏
页数:23
相关论文
共 50 条
  • [1] An overview of systematic reviews of complementary and alternative therapies for fibromyalgia using both AMSTAR and ROBIS as quality assessment tools
    Rachel Perry
    Verity Leach
    Philippa Davies
    Chris Penfold
    Andy Ness
    Rachel Churchill
    Systematic Reviews, 6
  • [2] A Systematic Overview of Reviews for Complementary and Alternative Therapies in the Treatment of the Fibromyalgia Syndrome
    Lauche, Romy
    Cramer, Holger
    Haeuser, Winfried
    Dobos, Gustav
    Langhorst, Jost
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2015, 2015
  • [3] A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2
    Perry, R.
    Whitmarsh, A.
    Leach, V.
    Davies, P.
    SYSTEMATIC REVIEWS, 2021, 10 (01)
  • [4] An overview of systematic reviews of complementary and alternative medicine for fibromyalgia
    Terry, Rohini
    Perry, Rachel
    Ernst, Edzard
    CLINICAL RHEUMATOLOGY, 2012, 31 (01) : 55 - 66
  • [5] An overview of systematic reviews of complementary and alternative therapies for infantile colic
    Rachel Perry
    Verity Leach
    Chris Penfold
    Philippa Davies
    Systematic Reviews, 8
  • [6] An overview of systematic reviews of complementary and alternative therapies for infantile colic
    Perry, Rachel
    Leach, Verity
    Penfold, Chris
    Davies, Philippa
    SYSTEMATIC REVIEWS, 2019, 8 (01)
  • [7] Quality assessment versus risk of bias in systematic reviews: AMSTAR and ROBIS had similar reliability but differed in their construct and applicability
    Banzi, Rita
    Cinquini, Michela
    Gonzalez-Lorenzo, Marien
    Pecoraro, Valentina
    Capobussi, Matteo
    Minozzi, Silvia
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2018, 99 : 24 - 32
  • [8] Quality Assessment and Risk of Bias of Systematic Reviews of Prophylactic Mesh for Parastomal Hernia Prevention Using AMSTAR and ROBIS Tools
    Garcia-Alamino, Josep M.
    Lopez-Cano, Manuel
    Kroese, Leonard
    Helgstrand, Frederik
    Muysoms, Filip
    WORLD JOURNAL OF SURGERY, 2019, 43 (12) : 3003 - 3012
  • [9] A comparison of two assessment tools used in overviews of systematic reviews: ROBIS versus AMSTAR-2
    R. Perry
    A. Whitmarsh
    V. Leach
    P. Davies
    Systematic Reviews, 10
  • [10] Phosphodiesterase type 5 inhibitors and premature ejaculation: an overview of systematic reviews/meta-analyses using the AMSTAR 2, ROBIS, and GRADE tools
    Abdel-Hamid, Ibrahim A.
    Abo-Aly, Mohamed
    Mostafa, Taymour
    SEXUAL MEDICINE REVIEWS, 2023, 11 (01) : 23 - 51